Abstract:Purpose Esophageal cancer is the most common gastrointestinal tumor and is difficult to be eradicated with conventional treatment. Porphyrin-based photosensitizers (PSs) mediated photodynamic therapy (PDT) could kill tumor cells with less damage to normal cells. As the most widely used porphyrin-based photosensitizer in clinics, Photofrin II has excellent anti-tumor effect. However, it has some disadvantages such as weak absorption at near infrared region, the complexity of components and prolonged skin photosensitivity. Here series novel 5,15-diaryl-10,20-dihalogeno porphyrin derivatives were afforded and evaluated to develop more effective and safer photosensitizers for tumor therapy. Methods The photophysical properties and singlet oxygen generation rates of 5,15-diaryl-10,20-dihalogeno porphyrins ( I 1-6 , II 1-4 ) were tested. The cytotoxicity of I 1-6 and II 1-4 were measured by MTT assay. The pathway of cell death was studied by flow cytometry. In vivo photodynamic efficacy of I 3 and II 2-4 in Eca-109 tumor-bearing BABL/c nude mice were measured and histopathological analysis were examined. Results 5,15-Diaryl-10,20-dihalogeno porphyrins I 1-6 and II 1-4 were synthesized. The longest absorption wavelength of these halogenated porphyrins ( λ max = 660 nm) displayed a red shift around 30 nm compared to the unhalogenated porphyrins PS 1 ( λ max = 630 nm). The singlet oxygen generation rates of I 1-6 and II 1-4 were significantly higher than PS 1 and HMME. All PSs mediated PDT showed obvious cytotoxic effect against Eca-109 cells compared to HMME in vitro and in vivo. Among these PSs, II 4 exhibited appropriate absorption in the phototherapeutic window, higher 1 O 2 generation rate ( k = 0.0061 s −1 ), the strongest phototoxicity (IC 50 = 0.4 μM), lower dark toxicity, high generation of intracellular ROS in Eca-109 cells and excellent photodynamic anti-tumor efficacy in vivo. Besides, cell necrosis was induced by compound II 4 mediated PDT. Conclusion All new compounds have obvious photodynamic anti-esophageal cancer effects. Among them, the photosensitizer II 4 showed excellent efficacy in vitro and in vivo, which has the potential to become a photodynamic anti-tumor drug.

Photodynamic Therapy of Oligoethylene Glycol Dendronized Reduction-Sensitive Porphyrins

Conjugated Oligo (phenylene Vinylene) Covalently Linked Porphyrin for Sonodynamic Therapy

Construction of Reduction-Responsive Photosensitizers Based on Amphiphilic Block Copolymers and Their Application for Photodynamic Therapy

Doxorubicin-loaded redox-responsive amphiphilic dendritic porphyrin conjugates for chemotherapy and photodynamic therapy

Redox-responsive supramolecular amphiphiles constructed via host-guest interactions for photodynamic therapy

N-Methylpyridylporphyrin Tailed with Folate Conjugate As a Potential Lysosomal-Targeted Photosensitizer: Synthesis, DNA Interaction, Singlet Oxygen and Subcellular Localization

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

Ultrasensitive Redox-Responsive Porphyrin-Based Polymeric Nanoparticles for Enhanced Photodynamic Therapy

Porphyrin photosensitizer molecules as effective medicine candidates for photodynamic therapy: electronic structure information aided design

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Self-Assembled Porphyrin-Peptide Cages for Photodynamic Therapy

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Water-soluble Porphyrin Photosensitizers Containing Electron-Withdrawing and Electron-Donating Groups for Photodynamic Therapy

Binary Organic Nanoparticles with Enhanced Reactive Oxygen Species Generation Capability for Photodynamic Therapy

Water-Soluble Porphyrin-Based Nanoparticles Derived from Electrostatic Interaction for Enhanced Photodynamic Therapy

Modulation of Glutathione Levels by Redox‐Active Nanogel Carriers for the Synergistic Enhancement of Photodynamic Therapy

Study of transient absorption spectroscopy of a D-π-A structure aggregation-induced emission luminogen and its photodynamic therapy application

Near-Infrared Light-Activated Photochemical Internalization of Reduction-Responsive Polyprodrug Vesicles for Synergistic Photodynamic Therapy and Chemotherapy.